In two papers published in Cell and Cell Host Microbe CViSB investigators, together with colleagues from our VIC sister consortium, describe in detail antibody responses to Ebola. By systematic analysis of a large set of more than 170 monoclonal antibodies to Ebola virus, the researchers show which immunological features play key roles in protection against the virus. The researchers aimed to…
A new study from VHFC researchers provide validation for a new rapid diagnostic test for Lassa fever. It is difficult to distinguish febrile illnesses that are common in West Africa from Lassa fever based solely on a patient’s clinical presentation. In this study, the field performance of recombinant antigen-based Lassa fever immunoassays was compared to that of quantitative polymerase chain…
We are looking for postdocs, administrators, and staff scientists to join us in our mission to identify the factors determining outcomes of human infectious disease. We are looking for both wet-lab and computational biologists – people interested in ‘field work’ in Sierra Leone are more than welcome to apply.
Scripps Research scientists receive $15 million to study viral outbreak survivors. With a new $15 million grant, scientists at Scripps Research are gearing up for an in-depth study of survivors of viral outbreaks.
Our Center just went online and we’ll be hiring shortly. In the meantime, please contact the individual labs for more information about upcoming positions.
